canertinib has been researched along with Local Neoplasm Recurrence in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campos, S; Charbonneau, C; Hamid, O; Hirte, H; Jordan, C; Kaldjian, EP; Lenehan, PF; Oza, A; Plante, M; Potkul, RK; Seiden, MV; Varterasian, ML | 1 |
1 trial(s) available for canertinib and Local Neoplasm Recurrence
Article | Year |
---|---|
Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Disease Progression; ErbB Receptors; Female; Humans; Middle Aged; Morpholines; Neoplasm Recurrence, Local; Oncogene Proteins v-erbB; Ovarian Neoplasms; Protein-Tyrosine Kinases; Survival Analysis; Treatment Outcome | 2005 |